The AECC DMA Sequencing Shared Resource was established in 1992 and has evolved considerably sincethen and, in particular, over the last funding period, to meet the evolving scientific needs of AECC membersand programs. The new name of this facility, Genomics Shared Resource, reflects this expansion of servicesand technologies. The facility now offers, in addition to DMA sequencing, fragment analysis, dHPLC forSNP/mutation discovery, Pyrosequencing SNP typing, pyrosequencing quantitative CpG methylation, andTaqman SNP typing. Real-time PCR is now provided as well. At the time of the last CCSG review, thisFacility provided Affymetrix services, and there was a separate cDNA printing facility. With the furtherdevelopment of microarray technologies, there has been a shift of emphasis to commercially availablemicroarrays. To meet the needs for epigenetic studies, services were contracted with NimbleGen Direct toperform, on their site, gene expression, CGH, chromatin immunoprecipitation on microarrays (ChlP-chip),and a novel genome-wide cytosine methylation assay developed at AECC. NimbleGen services aremanaged by this facility. Within the context of this application all of the microarray services (Affymetrix,NimbleGen and in-house printing) have now been consolidated in this shared resource to provide a singlesource of intellectual guidance to users and enhance cost-effectiveness. The facility provides access to threecomputer workstations with design and analysis software to support a number of the services. Over the pastfive years the capacity of the facility has been increased so that turnaround time has been substantiallydecreased and fees to users have been decreased.

Agency
National Institute of Health (NIH)
Institute
National Cancer Institute (NCI)
Type
Center Core Grants (P30)
Project #
2P30CA013330-35
Application #
7506853
Study Section
Subcommittee G - Education (NCI)
Project Start
2007-09-25
Project End
2012-06-30
Budget Start
2007-09-25
Budget End
2008-06-30
Support Year
35
Fiscal Year
2007
Total Cost
$177,853
Indirect Cost
Name
Albert Einstein College of Medicine
Department
Type
DUNS #
110521739
City
Bronx
State
NY
Country
United States
Zip Code
10461
Van Arsdale, Anne R; Arend, Rebecca C; Cossio, Maria J et al. (2018) Insulin-like growth factor 2: a poor prognostic biomarker linked to racial disparity in women with uterine carcinosarcoma. Cancer Med 7:616-625
Ruiz, Penelope D; Gamble, Matthew J (2018) MacroH2A1 chromatin specification requires its docking domain and acetylation of H2B lysine 20. Nat Commun 9:5143
Rohan, Thomas; Ye, Kenny; Wang, Yihong et al. (2018) MicroRNA expression in benign breast tissue and risk of subsequent invasive breast cancer. PLoS One 13:e0191814
Walters, Ryan O; Arias, Esperanza; Diaz, Antonio et al. (2018) Sarcosine Is Uniquely Modulated by Aging and Dietary Restriction in Rodents and Humans. Cell Rep 25:663-676.e6
Racine, Jeremy J; Stewart, Isabel; Ratiu, Jeremy et al. (2018) Improved Murine MHC-Deficient HLA Transgenic NOD Mouse Models for Type 1 Diabetes Therapy Development. Diabetes 67:923-935
Frimer, Marina; Miller, Eirwen M; Shankar, Viswanathan et al. (2018) Adjuvant Pelvic Radiation ""Sandwiched"" Between Paclitaxel/Carboplatin Chemotherapy in Women With Completely Resected Uterine Serous Carcinoma: Long-term Follow-up of a Prospective Phase 2 Trial. Int J Gynecol Cancer 28:1781-1788
Kale, Abhijit; Ji, Zhejun; Kiparaki, Marianthi et al. (2018) Ribosomal Protein S12e Has a Distinct Function in Cell Competition. Dev Cell 44:42-55.e4
Lee, Chang-Hyun; Kiparaki, Marianthi; Blanco, Jorge et al. (2018) A Regulatory Response to Ribosomal Protein Mutations Controls Translation, Growth, and Cell Competition. Dev Cell 46:456-469.e4
Mao, Serena P H; Park, Minji; Cabrera, Ramon M et al. (2018) Loss of amphiregulin reduces myoepithelial cell coverage of mammary ducts and alters breast tumor growth. Breast Cancer Res 20:131
Mocholi, Enric; Dowling, Samuel D; Botbol, Yair et al. (2018) Autophagy Is a Tolerance-Avoidance Mechanism that Modulates TCR-Mediated Signaling and Cell Metabolism to Prevent Induction of T Cell Anergy. Cell Rep 24:1136-1150

Showing the most recent 10 out of 1508 publications